SAB Biotherapeutics (SABSW) Q2 2024 Earnings

May 20Confirmed
Mar 2021
Jun 2021
Sep 2021
Q2 2024
-0.96
-0.64
-0.32
0

Details

Expected EPS
-0.96
Actual EPS
-0.54
Surprise EPS
0.42
Surprise Percent
+43.75%

Description

⁨SAB Biotherapeutics⁩ (⁦SABSW⁩) has reported earnings of ⁦-0.54⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts